1. Home
  2. GENK vs GDTC Comparison

GENK vs GDTC Comparison

Compare GENK & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GENK
  • GDTC
  • Stock Information
  • Founded
  • GENK 2011
  • GDTC 2018
  • Country
  • GENK United States
  • GDTC Singapore
  • Employees
  • GENK N/A
  • GDTC N/A
  • Industry
  • GENK Restaurants
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GENK Consumer Discretionary
  • GDTC Health Care
  • Exchange
  • GENK Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • GENK 36.5M
  • GDTC 29.4M
  • IPO Year
  • GENK 2023
  • GDTC 2023
  • Fundamental
  • Price
  • GENK $5.50
  • GDTC $2.56
  • Analyst Decision
  • GENK Strong Buy
  • GDTC Buy
  • Analyst Count
  • GENK 3
  • GDTC 1
  • Target Price
  • GENK $13.17
  • GDTC $5.00
  • AVG Volume (30 Days)
  • GENK 60.1K
  • GDTC 20.3K
  • Earning Date
  • GENK 03-05-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • GENK N/A
  • GDTC N/A
  • EPS Growth
  • GENK 483.78
  • GDTC N/A
  • EPS
  • GENK 0.17
  • GDTC N/A
  • Revenue
  • GENK $198,834,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • GENK $14.66
  • GDTC $14.71
  • Revenue Next Year
  • GENK $21.47
  • GDTC N/A
  • P/E Ratio
  • GENK $31.92
  • GDTC N/A
  • Revenue Growth
  • GENK 12.50
  • GDTC N/A
  • 52 Week Low
  • GENK $5.46
  • GDTC $1.20
  • 52 Week High
  • GENK $14.46
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • GENK 19.19
  • GDTC 46.58
  • Support Level
  • GENK $5.50
  • GDTC $2.46
  • Resistance Level
  • GENK $6.42
  • GDTC $2.94
  • Average True Range (ATR)
  • GENK 0.32
  • GDTC 0.21
  • MACD
  • GENK -0.04
  • GDTC -0.01
  • Stochastic Oscillator
  • GENK 2.88
  • GDTC 38.71

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: